CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in SPRY — ARS Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in SPRY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,416,842
+$133,689 QoQ
Shares Held
551,416
+3.4% QoQ
Ownership
0.554%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 209 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. SPRY ranks #150 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in SPRY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,416,842 | 551,416 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,283,153 | 533,394 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,418,357 | 550,932 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,233,617 | 520,758 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $7,716,424 | 442,202 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,241,545 | 416,657 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $4,509,882 | 427,477 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $6,147,231 | 423,947 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,536,160 | 415,530 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,528,914 | 345,295 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,805,934 | 329,550 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,226,243 | 324,403 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $479,793 | 71,611 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $105,266 | 16,170 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $137,930 | 16,170 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $451,195 | 106,414 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $517,286 | 147,375 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $991,960 | 148,943 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,388,267 | 139,105 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,650,485 | 85,804 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,682,939 | 84,413 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||